Clinical Trials in Minneapolis

Showing 4261-4280 of 11,007 trials

MAP to Health Pilot Study: A Physical Activity Intervention for Midlife Adults

NCT05332145

The study has two aims: (1) to develop and examine the acceptability of the technological and theoretical frameworks of MAP to Health and (2) to determine whether MAP to Health is related to changes in theoretically identified mechanisms of behavior change (meaning salience, basic psychological needs satisfaction, and internal motivation). In an exploratory aim, the study will assess how the intervention and mechanisms of change are related to changes in physical activity. Participants will be adults in midlife (ages 40-64) who are insufficiently active, are interested in increasing physical activity, do not have contraindications to engaging in physical activity, and are patients in a large healthcare system in the Midwest.

Physical Inactivity

HealthPartners Institute35 participantsStarted Nov 2022

Bloomington, Minnesota, United States

TERMINATED59 miles

Step and Walking Pattern From Cardiac Monitor Study

NCT04971993

To understand the feasibility of characterizing walking patterns in heart failure subjects and subjects at risk for arrhythmias using an investigational wearable monitor called the SWAN study system.

Heart Failure NYHA Class IIHeart Failure NYHA Class IIIInsertable Cardiac Monitor

Boston Scientific Corporation40 participantsStarted Jan 2022

Saint Cloud, Minnesota, United States

MAP to Health Pilot Study: A Physical Activity Intervention for Midlife Adults

Step and Walking Pattern From Cardiac Monitor Study

Find Trials by Condition in Minneapolis

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Approaches and Decisions for Acute Pediatric TBI Trial

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST) Study Multi-Center Study

Genetics of the Early and Late Response to Allergen Challenge

iCanCope With Sickle Cell Pain

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD)

Furosemide as Supportive Therapy for COVID-19 Respiratory Failure

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

International Lung Screen Trial (ILST)